Patents by Inventor Annie Clauss

Annie Clauss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
    Patent number: 8846670
    Abstract: The invention relates to compounds of the formula: or their racemic, enantiomeric or diastereoisomeric isomers, or pharmaceutically acceptable salts of the compounds of formula I or the racemic, enantiomeric or diasteroisomeric isomers.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: September 30, 2014
    Assignee: Sanofi
    Inventors: Eric Bacque, Maurice Brollo, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
    Patent number: 8828997
    Abstract: The invention relates to a product of formula (I) where R1, R2, R3, and R4 are as defined herein, the therapeutic use of the product, a process to make the product, and a pharmaceutical composition comprising the product.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: September 9, 2014
    Assignee: Sanofi
    Inventors: Maurice Brollo, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
    Patent number: 8722659
    Abstract: The subject matter of the invention is quinazolinedione derivatives of formula (I), methods for obtaining same and therapeutic uses thereof, such as cancer, diabetes, muscle diseases, bone diseases, cardiovascular diseases, central nervous system diseases, peripheral nervous system diseases, inter alia.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: May 13, 2014
    Assignee: Sanofi
    Inventors: Annie Clauss, Christophe Glaess, Gilbert Marciniak, Jean-Francois Nave, Bertrand Vivet
  • NOVEL 1,2,3,4-TETRAHYDRO-PYRIMIDO(1,2-A)PYRIMIDIN-6-ONE DERIVATIVES, PREPARATION THEREOF, AND PHARMACEUTICAL USE THEREOF
    Publication number: 20120208810
    Abstract: The invention relates to the novel materials of formula (I), where: R1 is an optionally substituted L-aryl or L-heteroaryl, such that L is a single bond, alkyl, CO, or CO-alk, or L-X, with L? being an alkyl and X being O or S; R2 is H or alkyl; R3 is an alkyl optionally substituted by Hal; and R4 is Hou Hal, wherein said materials are in any isomeric form and the salts thereof, to be used as drugs.
    Type: Application
    Filed: July 1, 2010
    Publication date: August 16, 2012
    Applicant: SANOFI
    Inventors: Eric Bacque, Maurice Brollo, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
    Patent number: 8242126
    Abstract: The invention relates to quinazolinedione derivatives of the general formula (I): wherein A, R1, R2, R3, R4, m, n, p, p?, and r are as defined herein, processes for the preparation thereof and their therapeutic applications.
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: August 14, 2012
    Assignee: Sanofi
    Inventors: Annie Clauss, Christophe Glaess, Gilbert Marciniak, Nicolas Muzet, Jean-Francois Nave, André Seyer, Bertrand Vivet
  • NOVEL 2,3-DIHYDRO-1H-IMIDAZO(1,2-A)PYRIMIDIN-5-ONE DERIVATIVES, PREPARATION THEREOF, AND PHARMACEUTICAL USE THEREOF
    Publication number: 20120142679
    Abstract: The invention relates to the novel materials of formula (I), where R1 is an optionally substituted L-aryl or -heteroaryl, such that L is: an alkyl or CO, or LX, with Lbeing an alkyl and X being O or S; R2 is H or an alkyl; R3 is an alkyl optionally substituted by Hal; and R4 is Hou Hal, wherein said materials are in any isomeric form and the salts thereof, to be used as drugs.
    Type: Application
    Filed: July 1, 2010
    Publication date: June 7, 2012
    Applicant: SANOFI
    Inventors: Maurice Brolio, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND VARIOUS THERAPEUTIC USES THEREOF.
    Publication number: 20120115846
    Abstract: The subject matter of the invention is quinazolinedione derivatives of formula (I), methods for obtaining same and therapeutic uses thereof, such as cancer, diabetes, muscle diseases, bone diseases, cardiovascular diseases, central nervous system diseases, peripheral nervous system diseases, inter alia.
    Type: Application
    Filed: October 7, 2011
    Publication date: May 10, 2012
    Applicant: SANOFI
    Inventors: Annie CLAUSS, Christophe GLAESS, Gilbert MARCINIAK, Jean-Francois NAVE, Bertrand VIVET
  • QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF
    Publication number: 20100298298
    Abstract: The invention relates to quinazolinedione derivatives, processes for the preparation thereof and their therapeutic applications.
    Type: Application
    Filed: April 5, 2010
    Publication date: November 25, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Annie CLAUSS, Christophe GLAESS, Gilbert MARCINIAK, Nicolas MUZET, Jean-Francois NAVE, André SEYER, Bertrand VIVET